PATENT CLAIM ANALYSIS

Application Number: 15952945
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "133100"]

Abstract:
The present inventors discovered that antibodies having weaker antigen-binding activity at the early endosomal pH in comparison with that at the pH of plasma are capable of binding to multiple antigen molecules with a single antibody molecule, have long half-lives in plasma, and have improved durations of time in which they can bind to antigen.

Claim (Index 70):
The method of  claim 66 , wherein the KD(pH5.8)/KD(pH7.4) value is 40 to 400.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 91.0
- Lexical Diversity: 1.31818
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13889512', '13889484', '13595139', '14741786', '12680087']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7935474862597967
- 35 USC 102 Novelty (BERT): 0.6610601475092862
- Combined Prediction Score: 0.7802987523847456
- Mean Citation Score: 654.3324599999999
- Max Citation Score: 879.704
- Similarity Product: 564.4634010019303

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test